Leprosy. An update: Definition, pathogenesis, classification, diagnosis, and treatment

135Citations
Citations of this article
269Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Leprosy is a chronic granulomatous disease caused by the bacillus Mycobacterium leprae. It primarily affects the skin and peripheral nerves and is still endemic in various regions of the world. Clinical presentation depends on the patient's immune status at the time of infection and during the course of the disease. Leprosy is associated with disability and marginalization. Diagnosis is clinical and is made when the patient has at least 1 of the following cardinal signs specified by the World Health Organization: hypopigmented or erythematous macules with sensory loss; thickened peripheral nerves; or positive acid-fast skin smear or skin biopsy with loss of adnexa at affected sites. Leprosy is treated with a multidrug combination of rifampicin, clofazimine, and dapsone. Two main regimens are used depending on whether the patient has paucibacillary or multibacillary disease. © 2011 Elsevier España, S.L. and AEDV. All rights reserved.

Cite

CITATION STYLE

APA

Eichelmann, K., González González, S. E., Salas-Alanis, J. C., & Ocampo-Candiani, J. (2013). Leprosy. An update: Definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermo-Sifiliograficas. Elsevier Doyma. https://doi.org/10.1016/j.ad.2012.03.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free